Stock search

Ticker or company name

Compare stocks

Market: US

  • DGXQuest Diagnostics
  • LHLabcorp
  • DXCMDexcom

Add stock

Ticker or company

Summary

DGX
Quest Diagnostics
$262,21Up +1,01%
Year: Up +38%
61/100Ratio would watch
Open stock page
LH
Labcorp
$372,46Up +0,53%
Year: Up +38%
56/100Ratio would watch
Open stock page
DXCM
Dexcom
$81,61Down −2,06%
Year: Up +40%
89/100Best scoreRatio would consider buying
Open stock page

Verdict

DXCM has the best score (89). DXCM grows revenue the fastest. LH is the cheapest by forward P/E. DXCM has the lowest debt load. DXCM has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckDGX3 ✓ 5 — 1 ✕LH3 ✓ 4 — 2 ✕DXCM8 ✓ 0 — 1 ✕
P/E vs its history25,530,031,4
P/E vs industry25,530,031,4
Forward P/E21,318,626,8
Revenue growth, YoY+9,1%+6,0%+13,0%
EPS growth, YoY+17,8%+19,6%+41,1%
Net margin9,5%6,9%19,4%
Net debt / EBITDA2,12,3−0,6
Free cash flow$1,38 bn$1,29 bn$1,10 bn
Share count over a year−0,9%−2,5%−5,9%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterDGXTTMLHTTMDXCMTTMIndustry medianTTM
P/E TTM ↓Best: 25,530,0Worst: 31,425,1
Forward P/E ↓21,3Best: 18,6Worst: 26,816,2
PEG ↓2,6Worst: 3,2Best: 1,42,2
P/S TTM ↓2,4Best: 2,1Worst: 6,12,2
EV/EBITDA ↓Best: 17,919,8Worst: 21,017,3
P/FCF ↓Best: 20,923,4Worst: 28,319,5

Price, %

  • DGXn/a
  • LHn/a
  • DXCMn/a

Returns

Best WorstNo mark — in between

PeriodDGXLHDXCM
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

DGXLHDXCM
Share of “buy”Worst: 52%78%Best: 89%
Beat the forecastBest: 4 of 4Worst: 3 of 4Worst: 3 of 4
Average “surprise”Best: +5,0%Worst: +0,6%+0,9%
Insiders over 12 monthssales $45,8 msales $11,7 msales $12,2 m

Details are on each stock page.